Is Immunosuppression Really Immunosuppression & How is it Relevant to Cancer: A Novel Paradigm

Time: 3:00 pm
day: Conference Day One

Details:

• The role of chronic inflammation in cancer development when immunosuppression/ immunomodulation may be useful in cancer therapy
• The role of the retinoic acid-related orphan receptor gamma (RORy) in chronic inflammation, fibrosis and cancer
• Targetting RORy(Immunosuppression) is not really immunosuppression but immunomodulation and is potentially beneficial in addressing the TME

Speakers:

Jean Tchervenkov Dr. Tchervenkov is a seasoned physician-scientist specializing in the immunology of transplantation. Based at McGill University’s Royal Victoria Hospital, his research focuses on immune tolerance, Read more